Phonak Audeo R Infinio 90 vs Signia Pure Charge&Go MaX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Phonak Audeo R Infinio 90
The Phonak Audeo R Infinio 90 is a premium prescription behind-the-ear hearing aid released in 2024, priced at $4,996. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #18 among 39 prescription hearing aids tested. Speech clarity is a standout strength in our testing. Speech in quiet scored 4.4/5, a strong result that sits 1.01 points above the category average. Speech in noise performance is more mixed at 2.5/5—above the category average by 0.37 points, but only moderate in absolute terms. This pattern suggests the Infinio 90 excels in calmer listening environments while offering incremental benefits in challenging noise. Streaming music quality impressed at 4.0/5, a strong score that lands 1.24 points above category average. Feedback handling scored 4.2/5, which is strong in absolute terms though 0.52 points below the category average. Own-voice comfort was mixed at 2.2/5, falling 0.50 points below average—something to discuss with your hearing care provider if natural voice quality is a priority. The Infinio 90 competes in a crowded premium segment. At this price point, alternatives like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieved higher overall scores in our testing. Buyers seeking Phonak's ecosystem and strong speech-in-quiet performance may find the Infinio 90 appealing, though those prioritizing noise performance or own-voice comfort should compare options carefully with their provider.
Choice

Signia Pure Charge&Go MaX
The Signia Pure Charge&Go MaX is a behind-the-ear prescription hearing aid released in 2026 that earns an A grade with a SoundScore of 4.3/5 in HearAdvisor's lab testing. This strong overall performance reflects solid results across key listening scenarios, with particular strengths in own-voice comfort and speech understanding in noisy environments. In our testing, the Pure Charge&Go MaX demonstrated notable advantages over the prescription hearing aid category average. Own-voice comfort scored 1.00 points above the category average at 3.7/5, suggesting effective management of occlusion-related issues that many hearing aid users find bothersome. Speech in noise performance measured 0.65 points above average at 2.8/5—above the category average, but only mixed in absolute terms, indicating room for improvement in the most challenging listening situations. Speech in quiet scored a solid 3.6/5, landing 0.24 points above the category average. Music streaming measured 2.9/5, slightly above average but mixed in absolute terms. Feedback handling scored an excellent 4.6/5 in absolute terms, though this fell 0.12 points below the category average of 4.72/5, reflecting the generally strong feedback control across modern prescription devices. The device showed meaningful improvement from initial to tuned fitting, with the normalized score rising from 4.2/5 to 4.6/5 after professional adjustment. This suggests that working with a hearing care professional to optimize settings can unlock additional performance, particularly for speech understanding. The Pure Charge&Go MaX appears well-suited for users who prioritize natural own-voice quality and improved conversation clarity in moderately noisy settings.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit